avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfe2
|
ENSMUSG00000058794.6 | nuclear factor, erythroid derived 2 |
Bach1
|
ENSMUSG00000025612.5 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
Mafk
|
ENSMUSG00000018143.4 | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfe2 | mm10_v2_chr15_-_103252810_103252829 | -0.82 | 9.8e-10 | Click! |
Mafk | mm10_v2_chr5_+_139791513_139791539 | -0.76 | 7.2e-08 | Click! |
Bach1 | mm10_v2_chr16_+_87698904_87698959 | -0.41 | 1.4e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 18.3 | GO:0006108 | malate metabolic process(GO:0006108) regulation of NADP metabolic process(GO:1902031) |
2.6 | 12.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
2.1 | 6.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.9 | 5.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.5 | 4.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.2 | 10.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.2 | 4.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.1 | 3.2 | GO:0060748 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.0 | 8.1 | GO:0019532 | oxalate transport(GO:0019532) |
1.0 | 3.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 2.7 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.9 | 3.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.8 | 5.5 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.7 | 4.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.6 | 2.4 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.6 | 2.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.6 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 3.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.5 | 2.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.5 | 4.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 12.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 8.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 1.5 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.5 | 2.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.8 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.4 | 1.3 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.4 | 10.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 1.3 | GO:0070256 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.4 | 4.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 3.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 2.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 1.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.4 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 1.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 5.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 2.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 9.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 3.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 1.6 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 1.9 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.5 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.3 | 3.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 1.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.8 | GO:0015881 | creatine transport(GO:0015881) |
0.3 | 1.8 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 1.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.7 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.2 | 0.7 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 2.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 4.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 1.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 6.1 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.2 | 4.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 2.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 3.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 3.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 4.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 3.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 2.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 1.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 2.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 4.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 1.4 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 4.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.5 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 4.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.3 | GO:1903465 | orbitofrontal cortex development(GO:0021769) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
0.1 | 15.8 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 0.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 1.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 2.9 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 1.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 1.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 4.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 2.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.1 | 5.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 1.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 2.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 1.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 1.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 2.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.2 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 1.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 3.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 1.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 2.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 2.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.7 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0021995 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.0 | 0.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 3.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.0 | 1.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 2.7 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.6 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.6 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 1.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 2.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 1.5 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 1.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 1.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 1.6 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 1.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 1.9 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 1.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 1.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 1.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.5 | 4.5 | GO:0044753 | amphisome(GO:0044753) |
0.7 | 7.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.7 | 4.1 | GO:0031673 | H zone(GO:0031673) |
0.6 | 6.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.6 | 3.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 1.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.4 | 5.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 9.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 3.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 4.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 3.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 1.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 3.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 7.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 3.2 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.9 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 4.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 6.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 3.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 1.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.6 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.9 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 4.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 4.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 4.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 8.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 2.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 3.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 3.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 25.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 7.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 9.1 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 1.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
5.1 | 20.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.0 | 15.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.6 | 6.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.4 | 5.5 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.4 | 4.1 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
1.2 | 6.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
1.2 | 3.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
1.0 | 4.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 9.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.9 | 3.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.9 | 4.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.8 | 10.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.7 | 2.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 5.8 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 1.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 3.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 6.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 2.8 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.5 | 1.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.5 | 1.5 | GO:0070540 | stearic acid binding(GO:0070540) |
0.5 | 1.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.5 | 3.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.5 | 8.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.5 | 1.9 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.4 | 12.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 1.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 7.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 1.1 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 2.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.8 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.3 | 6.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 4.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.4 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 4.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 3.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 2.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 4.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 1.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 2.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 4.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 2.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 3.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 4.1 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 3.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.5 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.1 | 2.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 2.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 2.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 13.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 5.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 2.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 3.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 9.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 2.8 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 7.6 | GO:0048037 | cofactor binding(GO:0048037) |
0.0 | 3.2 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.9 | GO:0051213 | dioxygenase activity(GO:0051213) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 11.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 8.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 5.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 5.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 8.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 5.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 3.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 2.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 3.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 8.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 33.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 2.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 14.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 4.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 9.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 6.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 19.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 7.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 8.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 3.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 1.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |